- Less expensive.
- Less error-prone.
- Significantly easier to perform.
Genomic Prediction provides advanced genetic testing for IVF. We have developed a novel, genome-wide molecular genotyping methodology for pre-implantation genetic testing of embryos.
Our approach reduces disease risk and improves newborn health outcomes by identifying candidate embryos for implantation which are genetically normal.
(of human disease)
October 31st marked Genomic Prediction’s debut product launch at the American Society for Reproductive Medicine (ASRM) annual conference in San Antonio, Texas. Simon Fishel of CARE was the first of new business collaborators to initialize with Genomic Prediction.
Genomic Prediction is engaged in a number of academic collaborations across the world. Our first embryo research collaboration has completed a first phase, successfully genotyping and karyotyping research embryo biopsies.
ⓖSEQ is in validation in partner labs across the world, having been tested to work equally well in other labs as on our own MiSeq sequencer. More collaborators welcome!